Here, we applied genome-wide DNA methylation and copy-number profiling, targeted next-generation DNA sequencing, and RNA sequencing to further biologically characterize and assess whether CNS tumors with PLAG1 gene fusions represent a third subtype related to the previously described ET, PLAGL. The gene discussed is PLAG1; the disease is central nervous system neoplasm.